![]() |
市场调查报告书
商品编码
1384662
心血管资讯系统全球市场规模、份额和行业趋势分析报告:2023-2030年按类型、营运模式和地区分類的展望和预测Global Cardiovascular Information System Market Size, Share & Industry Trends Analysis Report By Type (CVIS, and CPACS), By Mode Of Operation (Web-based, Cloud-based, and On-site), By Regional Outlook and Forecast, 2023 - 2030 |
心血管资讯系统市场规模预计到 2030 年将达到 22 亿美元,预测期内市场成长率为 10.2%。
根据KBV Cardinal矩阵中发布的分析,思科系统公司和甲骨文公司是该市场的先驱。 2021 年 7 月,思科系统公司宣布收购Socio Labs, Inc.,加强 Cisco Webex 平台产品并为客户提供更好的线上活动体验。霍尼韦尔国际公司、麦克森公司和西门子医疗公司等公司是该市场的主要创新者。
COVID-19 影响分析
由于大流行,医疗机构面临财务困难。许多资源被用于应对新冠肺炎 (COVID-19) 疫情,影响了其他医疗保健技术的资金投入。因此,一些医疗保健提供者推迟了对 CVIS 和其他非紧急系统的投资。大流行扰乱了医疗机构的正常业务。这推迟了包括车路协同在内的新技术的引入。因此,疫情对市场产生了较为正面的影响。 CVIS 的采用已成为医疗保健领域的关键因素,从而导致未来几年市场的积极成长。
市场成长要素
提高效率并优化工作流程
对医疗保健效率的重视导致了 CVIS 系统的采用,该系统简化了临床工作流程、减轻了管理负担并提高了患者照护的整体效率。市场透过提供专门的解决方案来满足这一需求,这些解决方案可以自动执行与资料搜寻、测试解释和报告生成相关的各种任务。这种优化透过实现快速诊断和治疗来直接影响患者的治疗结果,从而提高医疗保健提供者和患者的临床效果和满意度。资料驱动的医学正在推动对先进 CVIS 解决方案的需求,这些解决方案可以有效地捕获、储存和管理大量患者资料和诊断资讯。因此,对能够实现高效资料管理和工作流程最佳化的 CVIS 解决方案的需求不断增长,这证实了这些系统在现代医疗保健服务中发挥关键作用。
扩大医疗基础设施
人口的快速成长,特别是在都市区,增加了对医疗基础设施的需求。需要扩大设施和服务,以适应越来越多的寻求医疗服务的患者。随着世界人口高龄化,对解决与老龄化相关的健康问题并提供长期照护的医疗保健服务的需求日益增长。医疗基础设施的扩张通常包括建立新的循环系统和循环系统护理设施。 CVIS 解决方案可协助这些部门提供一个全面的平台来有效管理病患资料和诊断资讯。医疗保健基础设施的扩张正在创造对专业解决方案的需求,这些解决方案支持心血管患者资料和诊断资讯的有效管理,从而增强了市场的成长和重要性。
市场抑制因素
高实施成本和复杂性
与 CVIS 相关的高实施成本是许多医疗机构的主要障碍。这些成本包括硬体和软体采购、客製化、与现有系统的整合以及全面的员工培训。对于小型医疗机构和预算有限的机构来说,这些财务要求可能令人望而却步,并成为 CVIS 实施的障碍。因此,许多医疗保健提供者无法利用 CVIS 提供的先进资料管理和诊断功能,导致医疗保健服务中出现数位落差。这些挑战阻碍了市场扩张,并限制了 CVIS 在简化资料管理、增强诊断能力和改善患者照护所能提供的潜在优势。
按类型分類的展望
按类型划分,市场分为 CVIS 和 CPACS。 2022 年,CPACS 细分市场在市场中占据了重要的收益占有率。心血管影像存檔和通讯系统 (CPACS) 旨在管理心血管影像,例如超音波心动图、血管造影术和核医学扫描。 CPACS 提供了这些影像的安全储存库,使医疗保健专业人员可以轻鬆存取它们。 CPACS 确保心血管影像的品质和一致性,包括影像格式、解析度和压缩,这对于准确的诊断和治疗计划至关重要。
对营运模式的看法
从运作模式来看,市场有网路化、云端基础、现场化等特性。 2022 年,基于网路的细分市场收益占有率最高。网路为基础的 CVIS 可以透过任何具有网路浏览器的网路连线装置进行存取。这种弹性使医疗保健专业人员能够从多个位置检索患者资料和诊断资讯,从而促进远端存取和远端医疗。基于网路的 CVIS 不需要大量的现场基础设施或硬件,从而降低了初始实施成本。这使得它具有成本效益,特别是对于小型医疗机构。
区域展望
从区域来看,我们对北美、欧洲、亚太地区和拉丁美洲地区的市场进行了分析。 2022 年,北美市场占据市场最大收益占有率。根据国家医学图书馆的数据,经济发展、文化习俗、遗传倾向以及治疗方法趋势和风险因素的差异导致了北美地区心臟衰竭率的差异。美国和加拿大都是已开发国家,地理特征、经济和基础建设体系、文化传统相似。
The Global Cardiovascular Information System Market size is expected to reach $2.2 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period.
Over the forecast period, it is anticipated that the presence of quickly developing economies like China and India, where the healthcare system is rapidly improving, will accelerate the region's development. Thus, the Asia Pacific region would generate 25% share of the market by 2030. Due to a sharp rise in the number of patients, the region has seen a significant increase in healthcare spending, which has increased investments in R&D activities pertaining to cardiovascular diseases. Due to the development of novel and cutting-edge goods and technologies, the regional market has grown faster.
The major strategies followed by the market participants are Acquisitions as the key developmental strategy to keep pace with the changing demands of end users. For instance, In September, 2022, McKesson Corporation announced the acquisition of Rx Savings Solutions, to extend its biopharma services in prescription price transparency, catering to a broad spectrum of client requirements. Additionally, Cerner Corporation, a subsidiary of Oracle Corporation announced an agreement to acquire Kantar Health, to further build out its Learning Health Network consortium.
Based on the Analysis presented in the KBV Cardinal matrix; Cisco Systems, Inc. and Oracle Corporation are the forerunners in the Market. In July, 2021, Cisco Systems, Inc announced the acquisition of Socio Labs, Inc., to enhance Cisco Webex's platform offerings and would provide customers with a better experience in online events. Companies such as Honeywell International, Inc., McKesson Corporation, Siemens Healthineers AG are some of the key innovators in the Market.
COVID-19 Impact Analysis
Healthcare facilities faced financial constraints due to the pandemic. Many resources were diverted to address COVID-19, impacting the allocation of funds for other healthcare technologies. As a result, some healthcare providers deferred investments in CVIS or other non-urgent systems. The pandemic disrupted regular operations in healthcare facilities. This led to delays in the implementation of new technologies, including CVIS. Therefore, the pandemic had a comparatively positive impact on the market. The adoption of CVIS has become a key component in healthcare, leading to positive growth in the market in the coming years.
Market Growth Factors
Increased efficiency and workflow optimization
The emphasis on efficiency in healthcare has led to the adoption of CVIS systems that streamline clinical workflows, reducing administrative burdens and enhancing the overall efficiency of patient care. The market has responded to this demand by providing specialized solutions that automate various tasks related to data retrieval, test interpretation, and report generation. This optimization directly impacts patient outcomes, as it enables quicker diagnosis and treatment, resulting in improved clinical efficacy and satisfaction for healthcare providers and patients alike. Data-driven medicine has fueled the demand for advanced CVIS solutions that can efficiently capture, store, and manage vast amounts of patient data and diagnostic information. Therefore, the increasing demand for CVIS solutions that enable efficient data management and workflow optimization underscores these systems' pivotal role in modern healthcare delivery.
Expansion of healthcare infrastructure
Rapid population growth, particularly in urban areas, increases healthcare infrastructure demands. In order to accommodate the increasing number of patients looking for medical care, facilities, and services must be expanded. As the global population ages, there is a greater need for healthcare services to address age-related health issues and provide long-term care. Expanding healthcare infrastructure often includes establishing new cardiology departments and cardiovascular care facilities. CVIS solutions are instrumental in providing a comprehensive platform for managing patient data and diagnostic information efficiently within these departments. The expansion of healthcare infrastructure has bolstered the growth and significance of the market by creating a demand for specialized solutions that support the efficient management of cardiovascular patient data and diagnostic information.
Market Restraining Factors
High implementation costs and complexity
The high implementation costs associated with CVIS present a major hindrance to many healthcare facilities. These costs encompass the purchase of hardware and software and expenses related to customization, integration with existing systems, and comprehensive staff training. For smaller healthcare organizations or those operating with limited budgets, these financial requirements can be prohibitive, discouraging the adoption of CVIS. As a result, many healthcare providers are unable to access the advanced data management and diagnostic capabilities offered by CVIS, leading to a digital divide in healthcare services. These challenges hinder the expansion of the market, limiting the potential benefits these systems can offer in terms of streamlined data management, enhanced diagnostic capabilities, and improved patient care.
Type Outlook
On the basis of type, the market is classified into CVIS and CPACS. The CPACS segment recorded a significant revenue share in the market in 2022. The cardiovascular picture archiving and communication system (CPACS) is designed to manage cardiovascular images, including echocardiograms, angiograms, and nuclear medicine scans. It provides a secure repository for these images, making them readily accessible to healthcare professionals. CPACS ensures the quality and consistency of cardiovascular images, including image format, resolution, and compression, which is critical for accurate diagnosis and treatment planning.
Mode Of Operation Outlook
Based on mode of operation, the market is characterized into web-based, cloud-based, and on-site. The web-based segment garnered the highest revenue share in the market in 2022. Web-based CVIS is accessible from any internet-connected device with a web browser. This flexibility allows healthcare professionals to retrieve patient data and diagnostic information from different locations, promoting remote access and telemedicine. The initial costs of implementing web-based CVIS can be lower because it doesn't require extensive on-site infrastructure and hardware. This can make it more cost-effective, particularly for smaller healthcare institutions.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the market in 2022. According to the National Library of Medicine, differences in economic development, cultural practices, genetic predisposition, and trends in treatments and risk factors contribute to variations in heart failure rates across North America. The US and Canada are industrialized countries with similar geographic characteristics, economic and infrastructure systems, and cultural traditions.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Cisco Systems, Inc., Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), Lumedx Corporation (Intelerad Medical Systems Incorporated), Agfa-Gevaert Group, Honeywell International, Inc., and McKesson Corporation
Strategies Deployed in Cardiovascular Information System Market
Mergers & Acquisition:
Feb-2023: GE HealthCare Technologies, Inc. signed an agreement to acquire Caption Health, Inc., a healthcare technology company specializing in artificial intelligence-driven ultrasound guidance to improve the quality and accessibility of medical imaging. Through this acquisition, GE HealthCare would be focused on performing fundamental echocardiogram assessments and making it possible to identify early signs of conditions such as heart failure in high-risk individuals.
Sep-2022: McKesson Corporation announced the acquisition of Rx Savings Solutions (RxSS), a healthcare technology company specializing in innovative prescription drug cost-saving solutions for both consumers and employers. Through this partnership, McKesson Corporation would be able to extend its biopharma services in prescription price transparency, catering to a broad spectrum of client requirements.
Jul-2021: Cisco Systems, Inc announced the acquisition of Socio Labs, Inc., an American event management platform provider. The acquisition enhances Cisco Webex's platform offerings and would provide customers with a better experience in online events.
Apr-2021: Siemens Healthineers AG acquired Varian Medical Systems, Inc., a global leader in cancer treatment solutions, providing advanced radiotherapy, radiosurgery, and brachytherapy technologies to improve the lives of cancer patients. Through this partnership, Siemens aimed to tackle the rising demand for personalized, data-informed diagnostics and precise cancer treatment, equipping us to combat the escalating global cancer epidemic.
Apr-2021: Cerner Corporation, a subsidiary of Oracle Corporation announced an agreement to acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science industry, a division of Kantar Group. Through this acquisition, Cerner aimed to further build out its Learning Health Network consortium.
Feb-2021: Koninklijke Philips N.V. acquired BioTelemetry, Inc., a company that provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. Through this acquisition, Philips would be able to provide their clients with healthcare solutions with a primary focus on cardiac patients and other medical conditions, both within the hospital and in the comfort of their homes.
Aug-2020: Koninklijke Philips N.V. took over Intact Vascular, Inc., a medical device company focused on developing innovative solutions for the treatment of peripheral artery disease. Through this acquisition, Philips would be able to offer more solutions for Peripheral Artery Disease.
Product Launches:
Feb-2023: Honeywell International, Inc. introduced Spectra MG BIO fibers, a bio-based variation of Spectra fibres, known for their exceptional strength, durability, and lightweight properties, used in various applications including ballistic protection and industrial use.
Partnerships, Collaborations & Agreements:
Jul-2023: GE HealthCare Technologies, Inc., came into partnership with Elekta, a leader in radiation therapy, in the Indian market. Through this partnership, GE HealthCare would aim to facilitate greater efficiency, precision, and personalization throughout the entire cancer care journey, emphasizing our commitment to investing in solutions that enhance the quality of cancer care while making it more patient cantered.
Oct-2022: GE Healthcare came into collaboration, both companies would advance their efforts to streamline the oncology care process, focusing on enhanced data handling, pathology digitization, and simplified data retrieval.
Oct-2022: Siemens Healthineers AG came into partnership with iMedrix Systems Pvt Ltd., a healthcare technology company specializing in remote patient monitoring solutions and telemedicine services. Through this partnership, both companies would provide telecardiology technology to help their clients generate deeper insights into health.
Sep-2022: McKesson Corporation partnered with CVS Health, a diversified healthcare company that operates pharmacies, healthcare clinics, and health insurance services, focusing on improving access to quality healthcare and pharmaceuticals. Through this partnership, both companies would be able to fulfil the growing customer demands.
Jul-2020: Cerner Corporation, a subsidiary of Oracle Corporation came into partnership with Holon Solutions, a healthcare technology company focused on data integration and interoperability solutions to improve healthcare delivery and patient outcomes. Through this partnership, Cerner accelerated the development of, seamless clinical decision support at the point of care.
Oct-2019: LUMEDX, a subsidiary of Intelerad Medical Systems Incorporated, came into partnership with MedAxiom, a US-Based Business Consulting and Services company. Through this partnership, LUMEDX would aim to accelerate the enhancement of the HealthView Analytics (HVA) platform to provide better patient outcomes and significant cost savings.
Market Segments covered in the Report:
By Type
By Mode Of Operation
By Geography
Companies Profiled
Unique Offerings from KBV Research